Medication options in the treatment of treatment-resistant depression
โ Scribed by Saxby Pridmore; Yvonne Turnier-Shea
- Book ID
- 108930218
- Publisher
- Informa plc
- Year
- 2004
- Tongue
- English
- Weight
- 95 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0004-8674
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Concerns that SSRIs might increase suicide rates among depressed patients raise the question of whether the benefits of these medications warrant the risk they pose. Metaโanalyses of published and unpublished clinical trials reveal that the benef its of antidepressants over placebo are
In depression that is resistant to tricyclic antidepressant (TCA) therapy, the substitution of a selective serotonin re-uptake inhibitor (SSRI), clomipramine, or a monoamine oxidase (MAO) inhibitor has been recommended. However, adding an additional antidepressant medication from a different drug cl
Recently, there were some reports that major depression is accompanied by signiยฎcant alterations in the percentage and number of peripheral blood mononuclear cells (PBMCs), such as increased number of CD4 T cells, B cells (e.g. CD19 , CD21 ), number of leukocytes, monocytes and neutrophils and an in